European Equity Partners
Venture capitalInactiveGuernsey · Seed–Growth · 3 people tracked
This fund appears to be inactive.
UK Companies House records show EUROPEAN EQUITY PARTNERS LIMITED (no. 04919487) as dissolved. It is unlikely to be making new investments — this profile is kept for reference and historical accuracy.
Find your way into European Equity Partners
Investment thesis
EEP invests in life sciences companies aiming to build best-in-class technologies and business organisations with the potential to become global leaders in their field. Drawing on more than 25 years of sector experience, deep specialist knowledge and an established network, the firm backs early-stage growth companies and works closely with founders and management to help them realise their potential. As a privately owned investment company, EEP makes a limited number of highly selective investments and commits fully to each, providing dedication and hands-on engagement alongside capital.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 5 of 17 portfolio companiesBiotech ×4Medical Devices ×3Advanced Manufacturing ×2Enterprise Software ×2Hardware ×2Healthtech ×2AdTech ×1AgTech ×1
HQs:United States×4
Investments · 17 tracked
founders shown can be your intro pathAGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtechMedical DevicesSeattle, US
Alberto Santagostino(Chief Executive Officer and President)inKasper Møller(Chief Technical Officer and Executive Vice President, Europe & Japan Regions)inChristoph Winterhalter(Chief Business Officer)inYuichiro Tashiro(Executive Vice President, Corporate Functions)inCarrie Mygatt(Executive Vice President, Finance)Luca Alberici(Executive Vice President, Global Cell & Gene Technologies and General Manager, Milan Facility)in
Co-investorsBoulder Ventures
Specialty pharma company focused on women's health and addiction medicine; acquired by Norgine in 2020.
Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health.
AgTechBiotechFoodTech
Co-investorsNovo HoldingsCross-Border Impact Ventures
Integrated optical network transport
Sunnyvale, US
David F. Welch(Director)Thomas J. Fallon(Executive Officer, Director)Bob Jandro(Executive Officer)James L. Laufman(Executive Officer)David W. Heard(Executive Officer)Brad D. Feller(Executive Officer)
Co-investorsAccelW Capital PartnersWing
Corporate subscription management provider offering integrated administration of print and online information; sold via secondary MBO in 2012.
Co-investorsAndera Partners
Alphabet Inc. is a holding company that oversees a portfolio of businesses including Google, which provides internet search, advertising, and related services; cloud infrastructure; and productivity software.
AdTechAI & Machine LearningCloud Computing
Larry Page(CEO of Alphabet)Sergey Brin(President of Alphabet)
Co-investorsCanaan PartnersKhosla VenturesSherpalo VenturesBuilding Ventures
VERDOT designs and manufactures downstream purification solutions for biopharmaceutical and biotechnology companies to enable the production of therapeutic biologics.
Advanced ManufacturingBiotechHardwareMedical Devices
Charles Ruban(President and CEO)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Aster-CephacBio-Research LaboratoriesCMC BiologicsCriverPharmaKinetics LaboratoriesSgsTransmodeVerdotWhatsonwhen
Exits · 3
3 acquisitions · showing 2Azantaacq. by NorgineTransmodeacq. by Infinera
Portfolio news
latest coverage across their companiesPrincipals & officers · per Companies House
what is this? ⓘCorporate secretary · since 2003
Director · British · since 2003
Roderick Bruce Crawford — 75–100% of shares
Frequently asked questions
- How many investments has European Equity Partners made?
- European Equity Partners has 17 tracked investments, 3 of which have exited.
- What stage does European Equity Partners invest at?
- European Equity Partners invests at the Seed, Series A, Series B, Growth stages.
- What is European Equity Partners's typical check size?
- European Equity Partners typically writes checks of $540K – $10.8M.
- What sectors does European Equity Partners focus on?
- European Equity Partners focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is European Equity Partners located?
- European Equity Partners is headquartered in Guernsey, GG.
- Does European Equity Partners lead rounds?
- Yes, European Equity Partners leads investment rounds.
- Who does European Equity Partners co-invest with?
- European Equity Partners most often shares deals with Accel, Canaan Partners, Khosla Ventures, among 10 tracked co-investors.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.